Nurix Therapeutics (NRIX) Financials: Revenue & Earnings

NRIX price $26.93 +0.23 +0.88%

Ticker
NRIX
Price
$26.93
Change
+0.23 +0.88%
Market cap ?
$2.94B
P/E ?
10.10
Forward P/E ?
11.45
Dividend yield ?
0.00%
Beta ?
1.82
Sector
Healthcare
Industry
Biotechnology

Financials

20182019202020212022202320242025
3744900031115000178200002975000038627000769870005454900083980000

Nurix Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule and antibody therapies for the treatment of cancer, inflammatory conditions, and other diseases. The company develops NX-5948, an orally bioavailable BTK degrader, that is in Phase 2 clinical trials for the treatment of relapsed or refractory B-cell malignancies and…

Fair value

NRIX fair value $92.17. Price $26.93. Price is 71% below fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Model uncertainty high for this stock

Compare NRIX

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2027-02-17—-0.41—37.95M
2027-01-27—-0.46—37.95M
2026-10-124.73-0.60673.06M24.35M
2026-07-09-0.81-0.729.04M15.29M
2026-04-08-0.79-0.766.25M14.25M
2026-01-28-0.82-0.8413.58M13.40M
2025-10-09-1.03-0.847.89M12.26M
2025-07-09-0.52-0.7144.06M17.51M
2025-04-08-0.67-0.7218.45M15.82M
2025-01-28-0.75-0.6713.28M14.78M
2024-10-11-0.67-0.6712.59M12.81M
2024-07-11-0.71-0.6612.09M22.10M
2024-04-10-0.76-0.8016.59M17.30M
2024-02-15-0.77-0.5115.16M22.26M
2023-10-12-0.68-0.6918.47M15.98M
2023-07-13-0.45-0.6330.68M26.21M
2023-04-13-0.75-0.9012.69M10.87M
2023-02-09-0.87-0.686.78M17.17M
2022-10-06-0.90-0.9910.79M12.07M
2022-07-07-1.01-1.0011.43M10.51M
2022-04-07-0.95-0.899.62M9.27M
2022-01-27-0.85-0.677.40M13.19M
2021-10-14-0.65-0.6310.25M10.41M
2021-07-13-0.60-0.547.09M8.23M
2021-04-13-0.63-0.465.01M4.74M
2021-02-16-0.51-0.546.69M—
2020-10-14-0.59-0.414.08M3.78M
2020-07-24-0.60—2.86M—
2020-05-310.22—4.18M—
2019-11-30-0.65—1.86M—
2019-08-31-0.12—10.58M—
2019-05-31-0.94—9.44M—
2019-02-28-0.85—9.23M—

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-10-15Hansen GwennBuy1.45K$1.862.70K
2026-10-15Hansen GwennSell1.45K$25.0036.30K
2026-10-15Hansen GwennSell1.45K$1.862.70K
2026-10-14GREGORY JULIA PBuy22.58K$1.8642.00K
2026-10-14GREGORY JULIA PSell22.58K$23.40528.53K
2026-10-14GREGORY JULIA PSell22.58K$1.8642.00K
2026-10-02Ring ChristineSell5.79K$8.7250.45K
2026-10-02Ring ChristineBuy5.79K$8.7250.45K
2026-10-02Ring ChristineSell5.79K$23.19134.15K
2026-09-02Ring ChristineSell5.79K$8.7250.46K
2026-09-02Ring ChristineBuy5.79K$8.7250.46K
2026-09-02Ring ChristineSell5.39K$25.69138.42K
2026-09-02Ring ChristineSell400$26.6410.65K
2026-09-01Hansen GwennBuy1.45K$1.862.70K
2026-09-01Hansen GwennSell1.45K$25.4736.98K
2026-09-01Hansen GwennSell1.45K$1.862.70K
2026-08-05Hansen GwennBuy4.36K$1.868.10K
2026-08-05Hansen GwennSell4.36K$25.00108.90K
2026-08-05Hansen GwennSell4.36K$1.868.10K
2026-08-04Hansen GwennSell1.50K$23.8735.80K
2026-08-04Hansen GwennSell2.61K$24.6464.34K
2026-08-04van Houte HansSell1.79K$23.8942.86K
2026-08-04van Houte HansSell2.97K$24.6573.13K
2026-08-03Ring ChristineSell5.79K$8.7250.46K
2026-08-03Ring ChristineBuy5.79K$8.7250.46K
2026-08-03Ring ChristineSell16.59K$23.05382.36K
2026-07-30van Houte HansBuy3.57K——
2026-07-30van Houte HansSell2.85K$23.3866.52K
2026-07-30van Houte HansBuy2.86K——
2026-07-30van Houte HansBuy3.75K——
2026-07-30van Houte HansSell3.57K——
2026-07-30van Houte HansSell2.86K——
2026-07-30van Houte HansSell3.75K——
2026-07-30Ring ChristineSell3.57K——
2026-07-30Ring ChristineBuy3.57K——
2026-07-30Ring ChristineBuy2.86K——
2026-07-30Ring ChristineSell2.86K——
2026-07-30Ring ChristineSell3.85K$23.3889.95K
2026-07-30Ring ChristineBuy3.75K——
2026-07-30Ring ChristineSell3.75K——
2026-07-30Hansen GwennBuy3.57K——
2026-07-30Hansen GwennBuy2.86K——
2026-07-30Hansen GwennSell3.85K$23.3889.95K
2026-07-30Hansen GwennBuy3.75K——
2026-07-30Hansen GwennSell3.57K——
2026-07-30Hansen GwennSell2.86K——
2026-07-30Hansen GwennSell3.75K——
2026-07-02Ring ChristineSell5.79K$8.7250.46K
2026-07-02Ring ChristineBuy5.79K$8.7250.46K
2026-07-02Ring ChristineBuy5.22K$1.869.71K
2026-07-02Ring ChristineSell11.01K$23.56259.37K
2026-07-02Ring ChristineSell5.22K$1.869.71K
2026-06-25Hansen GwennSell5.39K$20.00107.88K
2026-06-25Ring ChristineSell15.60K$8.72136.05K
2026-06-25Ring ChristineBuy15.60K$8.72136.05K
2026-06-25Ring ChristineBuy13.33K$7.2696.80K
2026-06-25Ring ChristineSell28.93K$20.06580.51K
2026-06-25Ring ChristineSell13.33K$7.2696.80K
2026-06-02Ring ChristineBuy3.42K$1.866.36K
2026-06-02Ring ChristineSell8.15K$16.60135.25K
2026-06-02Ring ChristineSell3.42K$1.866.36K
2026-05-15Silva Paul MBuy31.25K$15.86495.62K
2026-05-15Saltzman Edward CBuy31.25K$15.86495.62K
2026-05-15Reinsdorf Judith ABuy31.25K$15.86495.62K
2026-05-15Lacey David L.Buy31.25K$15.86495.62K
2026-05-15Kapur AnilBuy31.25K$15.86495.62K
2026-05-15DANSEY ROGER DBuy31.25K$15.86495.62K
2026-05-15Baynes Roy D.Buy31.25K$15.86495.62K
2026-05-15GREGORY JULIA PBuy31.25K$15.86495.62K
2026-05-05van Houte HansSell13.47K$16.58223.32K
2026-05-05van Houte HansSell582$17.1810.00K
2026-05-04Ring ChristineSell8.15K$16.96138.21K
2026-05-01Ring ChristineSell5.39K$16.7690.41K
2026-04-30van Houte HansBuy2.86K——
2026-04-30van Houte HansSell2.39K$16.6539.75K
2026-04-30van Houte HansBuy3.75K——
2026-04-30van Houte HansBuy2.00K——
2026-04-30van Houte HansSell2.86K——
2026-04-30van Houte HansSell3.75K——
2026-04-30van Houte HansSell2.00K——
2026-04-30Ring ChristineBuy2.86K——
2026-04-30Ring ChristineBuy3.75K——
2026-04-30Ring ChristineSell3.21K$16.6553.50K
2026-04-30Ring ChristineBuy2.00K——
2026-04-30Ring ChristineSell2.86K——
2026-04-30Ring ChristineSell3.75K——
2026-04-30Ring ChristineSell2.00K——
2026-04-30Hansen GwennBuy2.86K——
2026-04-30Hansen GwennBuy3.75K——
2026-04-30Hansen GwennSell3.21K$16.6553.50K
2026-04-30Hansen GwennBuy2.00K——
2026-04-30Hansen GwennSell2.86K——
2026-04-30Hansen GwennSell3.75K——
2026-04-30Hansen GwennSell2.00K——
2026-04-02Ring ChristineSell8.15K$15.24124.15K
2026-03-02Ring ChristineSell8.15K$15.44125.79K
2026-02-10van Houte HansBuy93.75K$16.451.54M
2026-02-10van Houte HansBuy42.88K——
2026-02-10Ring ChristineBuy93.75K$16.451.54M
2026-02-10Ring ChristineBuy42.88K——

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 218, holders +20 vs prior quarter. Ownership 106.31%.

HolderSharesChangeChange %Value
BLACKROCK, INC.8.77M-155.29K-1.74%212.77M
VESTAL POINT CAPITAL, LP8.05M1.55M+23.85%195.29M
DEEP TRACK CAPITAL, LP7.74M1.39M+21.93%187.69M
RUBRIC CAPITAL MANAGEMENT LP7.23M4.75M+192.16%175.35M
FMR LLC5.49M-56.06K-1.01%133.07M
PRICE T ROWE ASSOCIATES INC /MD/5.44M2.15M+65.23%131.89M
MORGAN STANLEY4.76M-169.51K-3.44%115.54M
STATE STREET CORP4.68M-463.95K-9.02%113.47M
BAKER BROS. ADVISORS LP4.66M00.00%113.02M
VANGUARD CAPITAL MANAGEMENT LLC4.50M68.42K+1.55%109.06M
PERCEPTIVE ADVISORS LLC4.32M609.54K+16.43%104.81M
REDMILE GROUP, LLC4.07M-3.66M-47.32%98.83M
GENERAL ATLANTIC, L.P.3.03M-1.07M-26.08%73.56M
GEODE CAPITAL MANAGEMENT, LLC2.54M17.06K+0.68%61.57M
PICTET ASSET MANAGEMENT HOLDING SA2.35M-374.91K-13.75%57.04M
ARK INVESTMENT MANAGEMENT LLC1.79M72.06K+4.19%43.50M
CAPITAL WORLD INVESTORS1.79M894.59K+100.14%43.37M
TRAILS EDGE CAPITAL PARTNERS, LP1.57M-170.00K-9.75%38.17M
VANGUARD PORTFOLIO MANAGEMENT LLC1.48M380.60K+34.53%35.97M
CITADEL ADVISORS LLC1.48M133.32K+9.92%35.83M
SOLEUS CAPITAL MANAGEMENT, L.P.1.47M527.00K+56.17%35.54M
DIMENSIONAL FUND ADVISORS LP1.43M650.62K+83.34%34.72M
EVENTIDE ASSET MANAGEMENT, LLC1.30M00.00%31.49M
BRAIDWELL LP1.29M-464.00K-26.50%31.22M
KYNAM CAPITAL MANAGEMENT, LP1.19M00.00%28.98M

Earnings and financials

Nurix Therapeutics, Inc. (NRIX) trades at $26.93, with a market cap of $2.94B and a trailing P/E of 10.10. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

20182019202020212022202320242025
3744900031115000178200002975000038627000769870005454900083980000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Nurix Therapeutics (NRIX) Financials: Revenue & Earnings

NRIX$26.93+0.23 +0.88%

$2.94B

Market Cap

10.10

P/E

11.45

Forward P/E

—

Score

Price History